Abstract
Due to the huge market potential in the stem cell research field, especially in the field of embryonic stem cell research, some scientists have predicted that effective stem cell treatment for diabetes, liver and blood diseases, Alzheimer disease, etc. will go to clinical practice in the near future. According to reports, the potential market return of stem cell treatment will amount to ca. $80 billion in the nearest future and, if the related pharmaceutical products are combined, the market size will amount to $400 billion in 2020.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Guangliang, T. (2009). Patentability of Research Results in Connection with Human-Embryonic Stem Cells, especially with the So-Called Therapeutic Cloning – Chinese Points of View. In: Straus, J., Ganea, P., Shin, YC. (eds) Patentschutz und Stammzellforschung. MPI Studies on Intellectual Property, Competition and Tax Law, vol 13. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02496-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-02496-2_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02495-5
Online ISBN: 978-3-642-02496-2
eBook Packages: Humanities, Social Science (German Language)